| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744955 | Clinical Microbiology and Infection | 2018 | 13 Pages |
Abstract
Clinicians should be aware of the risk of immune-related adverse effects and PML in patients receiving immune checkpoint and cell adhesion inhibitors respectively.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
G. Redelman-Sidi, O. Michielin, C. Cervera, C. Ribi, J.M. Aguado, M. Fernández-Ruiz, O. Manuel,